Anne Misher

1.2k total citations
18 papers, 597 citations indexed

About

Anne Misher is a scholar working on Pharmacology, Pharmacology and Molecular Biology. According to data from OpenAlex, Anne Misher has authored 18 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 4 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in Anne Misher's work include Drug-Induced Hepatotoxicity and Protection (3 papers), Pharmacological Effects of Natural Compounds (2 papers) and Gastroesophageal reflux and treatments (1 paper). Anne Misher is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (3 papers), Pharmacological Effects of Natural Compounds (2 papers) and Gastroesophageal reflux and treatments (1 paper). Anne Misher collaborates with scholars based in United States, Qatar and Uruguay. Anne Misher's co-authors include D. T. Walz, Michael J. DiMartino, Blaine M. Sutton, Lawrence W. Chakrin, Óscar R. Burrone, Richard J. Staples, Joseph V. Swintosky, George M. Irwin, H.B. Kostenbauder and Lewis W. Dittert and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Annals of the Rheumatic Diseases and Journal of Pharmaceutical Sciences.

In The Last Decade

Anne Misher

18 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Misher United States	11	161	93	90	89	88	18	597
Atul Khandwala United States	17	261 1.6×	97 1.0×	35 0.4×	243 2.7×	65 0.7×	47	892
Peter P.K. Ho United States	14	331 2.1×	116 1.2×	77 0.9×	101 1.1×	36 0.4×	26	612
Ben J. van der Walt South Africa	14	150 0.9×	66 0.7×	19 0.2×	43 0.5×	53 0.6×	25	564
Geeta Rai India	18	244 1.5×	110 1.2×	131 1.5×	71 0.8×	72 0.8×	51	818
Katsuya Yamasaki Japan	15	163 1.0×	151 1.6×	17 0.2×	103 1.2×	54 0.6×	30	832
Luigi Candussio Italy	15	231 1.4×	47 0.5×	26 0.3×	52 0.6×	255 2.9×	42	664
Görkem Kısmalı Türkiye	16	248 1.5×	61 0.7×	41 0.5×	86 1.0×	115 1.3×	53	814
D. T. Walz Canada	19	314 2.0×	182 2.0×	188 2.1×	279 3.1×	253 2.9×	45	1.3k
Morris S. Zedeck United States	14	223 1.4×	46 0.5×	15 0.2×	78 0.9×	171 1.9×	33	657
Susumu Yamato Japan	18	392 2.4×	67 0.7×	21 0.2×	51 0.6×	36 0.4×	71	925

Countries citing papers authored by Anne Misher

Since Specialization

Citations

This map shows the geographic impact of Anne Misher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Misher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Misher more than expected).

Fields of papers citing papers by Anne Misher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Misher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Misher. The network helps show where Anne Misher may publish in the future.

Co-authorship network of co-authors of Anne Misher

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Misher. A scholar is included among the top collaborators of Anne Misher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Misher. Anne Misher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Misher, Anne, et al.. (2020). Sodium–Glucose Cotransporter-2 Inhibitors and the Risk of Amputation: What Is Currently Known?. American Journal of Therapeutics. 28(1). e96–e110. 3 indexed citations

Khorassani, Farah, et al.. (2015). Past and present of antiobesity agents: Focus on monoamine modulators. American Journal of Health-System Pharmacy. 72(9). 697–706. 19 indexed citations

Shahin, Mohamed H., Larisa H. Cavallari, Minoli A. Perera, et al.. (2013). VKORC1 Asp36Tyr geographic distribution and its impact on warfarin dose requirements in Egyptians. Thrombosis and Haemostasis. 109(6). 1045–1050. 21 indexed citations

Misher, Anne, et al.. (2012). Assessing the utility of whole genome amplified DNA as a template for DMET Plus array. Clinical Chemistry and Laboratory Medicine (CCLM). 50(8). 1329–34. 8 indexed citations

Misher, Anne, et al.. (2012). A Capillary Electrophoresis Method for Genotyping the 9-bp Exon 1 Insertion/Deletion in BDKRB2. Pharmacogenomics. 13(3). 353–358. 5 indexed citations

Burrone, Óscar R., et al.. (1977). Effect of auranofin on DNA and protein synthesis in human lymphocytes.. PubMed. 4(3). 245–51. 38 indexed citations

Macko, Edward, et al.. (1977). Fluotracen: a tricyclic compound with the combined properties of antidepressants and antipsychotics in animals.. PubMed. 27(8). 1589–95. 3 indexed citations

Walz, D. T., Michael J. DiMartino, Lawrence W. Chakrin, Blaine M. Sutton, & Anne Misher. (1976). Antiarthritic properties and unique pharmacologic profile of a potential chrysotherapeutic agent: S K & F D-30162.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 197(1). 142–52. 62 indexed citations

Walz, D. T., Michael J. DiMartino, Lawrence W. Chakrin, Blaine M. Sutton, & Anne Misher. (1976). Antiarthritic properties and unique pharmacologic profile of a potential chrysotherapeutic agent: S K & F D-30162.. Journal of Pharmacology and Experimental Therapeutics. 197(1). 142–152. 10 indexed citations

10.

Walz, D. T., et al.. (1976). Auranofin. New oral gold compound for treatment of rheumatoid arthritis.. Annals of the Rheumatic Diseases. 35(3). 251–257. 185 indexed citations

11.

Walz, D. T., Michael J. DiMartino, Blaine M. Sutton, & Anne Misher. (1972). SK&F 36914-AN AGENT FOR ORAL CHRYSOTHERAPY. Journal of Pharmacology and Experimental Therapeutics. 181(2). 292–297. 2 indexed citations

12.

Walz, D. T., Michael J. DiMartino, Blaine M. Sutton, & Anne Misher. (1972). SK&F 36914--an agent for oral chrysotherapy.. PubMed. 181(2). 292–7. 36 indexed citations

13.

Walz, D. T., Michael J. DiMartino, & Anne Misher. (1971). ADJUVANT-INDUCED ARTHRITIS IN RATS. II. DRUG EFFECTS ON PHYSIOLOGIC, BIOCHEMICAL AND IMMUNOLOGIC PARAMETERS. Journal of Pharmacology and Experimental Therapeutics. 178(1). 223–231. 103 indexed citations

14.

Walz, D. T., et al.. (1971). Suppression of adjuvant-induced arthritis in the rat by gold sodium thiomalate.. Annals of the Rheumatic Diseases. 30(3). 303–306. 29 indexed citations

15.

Misher, Anne, et al.. (1970). Investigation of the carrageenin-induced rat paw edema assay and correlation between anti-inflammatory activity and gastric hemorrhage production in the rat.. PubMed. 185(2). 337–43. 4 indexed citations

16.

Irwin, George M., H.B. Kostenbauder, Lewis W. Dittert, et al.. (1969). Enhancement of Gastrointestinal Absorption of a Quaternary Ammonium Compound by Trichloroacetate. Journal of Pharmaceutical Sciences. 58(3). 313–315. 52 indexed citations

17.

Misher, Anne, et al.. (1968). Pharmacology of the Hexylcarbonate of Salicylic Acid. Journal of Pharmaceutical Sciences. 57(7). 1128–1131. 4 indexed citations

18.

Staples, R., et al.. (1967). Gastrointestinal Irritant Effect of Glycerin as Compared with Sorbitol and Propylene Glycol in Rats and Dogs. Journal of Pharmaceutical Sciences. 56(3). 398–400. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact